This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Carlo Boutton, PhD
Global Head Innovation, Large Molecule Research Pl at Sanofi


Carlo Boutton obtained his PhD in 1999 at the University of Leuven (Belgium) on a subject that investigated the physico-chemical behavior of proteins under high-electromagnetic (laser) fields.

After his PhD he joined Algonomics (currently Lonza) where he contributed to the development of EpiBase: a platform to predict and identify T-cell epitopes in biologics. In 2003 he joined Tibotec (subsidiary of Johnson & Johnson) where he was involved in several anti-HIV and anti-HCV projects. He joined Ablynx in 2007 where he focused on improvements of the NANOBODY platform and new therapeutic applications, including bispecifics, immunotherapeutics and ADCs. After the acquisition of Ablynx by Sanofi he continued focusing on innovation and currently holds the position of Global Head Innovation of the Large Molecules Research platform at Sanofi.

Agenda Sessions

  • The NANOBODY Platform – From Discovery to Market